Skip to main content
. Author manuscript; available in PMC: 2019 Sep 11.
Published in final edited form as: Curr Cancer Drug Targets. 2019;19(7):515–524. doi: 10.2174/1568009618666181018162117

Table 1.

Potential HSF1 biomarkers for cancer patient outcomes.

HSF1 Marker Patient Outcome Tumor Types References
Gene Expression Signature Overall Survival Breast, Lung, Colon [12]
Metastasis-Free Survival Breast, Lung, Colon [12, 54]
mRNA Levels Overall Survival Esophageal, Breast [23, 42]
Recurrence-Free Survival Breast [42]
Incidence Colorectal [9]
Protein Levels Overall Survival Esophageal, Pancreatic, Hepatocellular, Breast, Osteosarcoma, Renal [13, 17, 23, 28, 34, 35, 90, 91]
Recurrence-Free Survival Esophageal, Pancreatic, Hepatocellular, Osteosarcoma [17, 28, 35, 91]
Disease-Specific Survival Endometrial, Renal [30, 34]
Nuclear Protein Levels Overall Survival Breast [12, 13]
Recurrence-Free Survival Melanoma [24]
Stromal Protein Levels Overall Survival Esophageal [91]
Recurrence-Free Survival Esophageal [91]
Phospho-S326 Levels Overall Survival Ovarian [32]